Skip to main content
Clinical Trials/DRKS00031199
DRKS00031199
Recruiting
Not Applicable

Real-world clinical characteristics, treatment patterns and outcomes in locally advanced or metastatic non-small cell lung cancer patients in Germany (I-O OPTIMISE/VONKO-014) - VONKOdb Advanced NSCLC 2024

Bristol Myers Squibb0 sites50,000 target enrollmentFebruary 15, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C34
Sponsor
Bristol Myers Squibb
Enrollment
50000
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 15, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • diagnosis years 2016\-2022
  • \- place of residence in respective federal state of cancer registry

Exclusion Criteria

  • patient is known to the cancer registry only by means of death certificate, a pathology report, a follow up notification, a tumor conference report or a combination of the aforementioned

Outcomes

Primary Outcomes

Not specified

Similar Trials